Megaloblastic anemia is defined as a macrocytic disorder resulting from impaired DNA synthesis due to Vitamin B9 (folate) or Vitamin B12 deficiency, which inhibits cellular maturation and division in hematopoietic tissues. The physiological mechanism involves the accumulation of nucleated precursors such as megaloblasts and hypersegmented neutrophils in peripheral circulation because these nutrients are essential cofactors for purine/pyrimidine synthesis required during rapid cell replication cycles. Differentiation between folate deficiency anemia, Vitamin B12 deficiency anemia, hereditary spherocytosis (an extravascular hemolytic process), sickle cell disease (a qualitative hemoglobinopathy causing vaso-occlusion and intravascular destruction), paroxysmal nocturnal hemoglobinuria, and G6PD deficiency relies on distinct biochemical pathways regarding nucleotide production or red blood cell membrane integrity against oxidative stress.
Megaloblastic anemia is defined as a macrocytic disorder resulting from impaired DNA synthesis due to Vitamin B9 (folate) or Vitamin B12 deficiency, which inhibits cellular maturation and division in…